Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang · 2024
Read Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities by Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11775542.txt.
Description
Mohammad Burhan Uddin, Zhishan Wang, and Chengfeng Yang review how a chemical mark on RNA helps cancers resist treatment. New drugs have grown for chemo, radiation, immune therapy, and targeted therapy alike. Yet tumours often bounce back in a tougher form once they learn to resist a drug. One fresh route to resistance runs through marks placed on RNA, the cell message copy, with the m6A mark the best known of them.
The review sums up how this mark and the proteins that place, read, and strip it drive resistance. Each drug class gets its own section, since the route to failure can differ by drug. Drugs aimed at the mark system could restore response in some tumours. The authors weigh that hope with care, since the same system does normal jobs in healthy cells. Gaps that block clinical use are named at the end.
Catalog record
| CREATOR | Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 105 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |